Monitor for additional insider selling in coming weeks. A single CEO sale of this size is within routine range and not necessarily bearish, but could signal reduced conviction if followed by further divestitures.
CORT drugs
CORT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 20 $34.64entry
- T+1 · 8mo ago −2.92%α −4.02% · $33.63
- T+5 · 8mo ago +8.54%α +10.70% · $37.60
- T+20 · 7mo ago +33.78%α +24.46% · $46.34
- T+60 · 5mo ago +139.35%α +124.93% · $82.91
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Corcept Therapeutics CEO Joseph Belanoff sold $1.31M worth of shares in a single open-market transaction. This represents a modest insider sale from the CEO, with no other insiders trading in the past 7 days.
Key Financial Metrics
Key Facts
- CEO Joseph Belanoff sold 26,198 shares at $50.0735 per share on March 25, 2026.
- Total value of the sale: $1,311,825.55.
- This transaction was an open-market sale (Form 4 code 'S').
- No other insider trades at CORT in the past 7 days.
Financial Impact
$1.31M in open-market sales by CEO
Risk Factors
- Potential perception of insider pessimism if no clear rationale is provided.
- Concentration risk in leadership ownership following sale.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (1 trades, 7d window) | cluster-CORT-1774643311298 |
Track record
36 reports on CORT
8 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +63.06% at T+60 after the Feb 24, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 13, 20262d ago Insider Cluster Neutral 2/10 Entry $73.87 Now $69.22 −6.29% settles Dec 15
- Nov 10, 20265d ago 144 Neutral 2/10 Entry $74.53 Now $69.22 −7.12% settles Dec 10
- Nov 4, 202611d ago Insider Cluster Neutral 2/10 Entry $71.63 Now $69.22 −3.36% settles Dec 4
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $79.22 Now $69.22 −12.62% settles Dec 3
- Nov 2, 202613d ago Institutional Cluster Bearish 4/10 Entry $81.93 Now $69.22 +15.51% settles Dec 2
- Oct 27, 202619d ago SC 13G/A Neutral 3/10 Entry $86.28 Now $69.22 −19.77% settles Nov 25
- Oct 5, 20265w ago Insider Cluster Neutral 3/10 Entry $119.57 to $81.93 Now $69.22 −42.11% ▼ −31.48% −28.30% vs SPY
- Sep 23, 20267w ago 8-K Neutral 3/10 Entry $112.94 to $116.28 Now $69.22 −38.71% ▲ +2.96% +2.27% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.50% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.75% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers